C. Karagiannidis (Cologne, Germany), C. Fisser (Regensburg, Germany)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Ventilation management in COVID–19 ARDS vs ARDS from another origin
A. Tsonas (Amsterdam, Netherlands), M. Botta (Amsterdam, Netherlands), A. Serpa Neto (Amsterdam, Netherlands), J. Horn (Amsterdam, Netherlands), F. Paulus (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands)
|   |
Risk stratification using SpO2/FiO2 and PEEP in COVID-19 ARDS
J. Roozeman (Amsterdam, Netherlands), A. Serpa Neto (Amsterdam, Netherlands), M. Hollmann (Amsterdam, Netherlands), F. Paulus (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), G. Mazzinari (Valencia, Spain), L. Pisani (Acquaviva delle Fonti, Italy)
| |
Prognosis factors influencing three-month respiratory outcomes in intensive care unit survivors after COVID-19 pneumonia
S. Karaer (Besançon, France), G. Eberst (Besançon, France), F. Claudé (Besançon, France), L. Laurent (Besançon, France), A. Meurisse (Besançon, France), P. Roux-Claudé (Besançon, France), C. Barnig (Besançon, France), K. Bouiller (Besançon, France), C. Chirouze (Besançon, France), J. Behr (Besançon, France), F. Grillet (Besançon, France), O. Ritter (Besançon, France), S. Pili-Floury (Besançon, France), H. Winiszewski (Besançon, France), E. Samain (Besançon, France), G. Capellier (Besançon, France), V. Westeel (Besançon, France)
| |
Risk factors and prognostic impact of ventilatory support in HIV patients on Intensive Care Unit (ICU)
A. Schulze (Münster, Germany), F. Rosenow (Münster, Germany), M. Mohr (Münster, Germany), G. Evers (Münster, Germany)
| |
Evolution of respiratory and biopsychosocial affectation in critical COVID19 patients after hospital discharge.
C. Manzano Senra (Lleida, Spain), S. Santisteve (Lleida, Spain), P. Carmona (Lleida, Spain), A. Monge (Lleida, Spain), A. Moncusi-Foix (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), R. Vacas (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain), F. Barbé (Lleida, Spain), J. González (Lleida, Spain)
| |
Characterisation of COVID-19 hospitalised frail patients not for ICU admission
Y. Noeman Ahmed (Southend, United Kingdom), M. Noeman (London, United Kingdom), A. Bedir (Southend, United Kingdom), I. El Sayed (Alexandria, Egypt), A. Roshdy (Alexandria, Egypt), C. Bansal (Southend University Hospital, United Kingdom), P. Ayuen (St Peters Hospital, United Kingdom), N. Abualela (St Peters Hospital, United Kingdom), S. Sharma (St Peters Hospital, United Kingdom)
| |
Using Machine Learning to Predict mortality for first-day COVID-19 patients presenting to the ICU
E. Jamshidi (Lausanne, Switzerland), S. Rahi (Lausanne, Switzerland), N. Mansouri (Lausanne, Switzerland)
| |
Surgical facemask affects fugitive emissions during aerosol drug delivery by high-flow nasal therapy
B. Murphy (Galway, Ireland), M. Macgiollaeain (Galway, Ireland), E. Fernández Fernández (Galway, Ireland), G. Bennett (Galway, Ireland), R. Macloughlin (Galway, Ireland)
| |
Awake prone position in hypoxemic Covid 19 Pneumonia: Does it reduce the mortality rate?
I. Mejri Ep Ajili (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), M. Kacem (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), Z. Moatemri (Tunis, Tunisia), M. Khadhraoui (Tunis, Tunisia)
| |
Gender differences in ventilation management in COVID-19
P. Swart (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), A. Serpa Neto (São Paulo, Brazil), F. Paulus (Amsterdam, Netherlands)
| |
Assessment of lung re-aeration at two levels of PEEP in patients with early and late COVID-19 related ARDS – a retrospective analysis
M. Smit (Amsterdam, Netherlands), L. Beenen (Amsterdam, Netherlands), C. Valk (Amsterdam, Netherlands), M. De Boer (Amsterdam, Netherlands), M. Scheerder (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands), F. Paulus (Amsterdam, Netherlands), J. Horn (Amsterdam, Netherlands), A. Vlaar (Amsterdam, Netherlands), F. Kooij (Amsterdam, Netherlands), M. Hollmann (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands)
| |
Derivation and validation of a simple score to help ruling-out COVID-19 in the Emergency Department
J. Giamello (Turin, Italy), G. Paglietta (Turin, Italy), G. Cavalot (Cuneo, Italy), A. Allione (Cuneo, Italy), S. Abram (Cuneo, Italy), L. Dutto (Cuneo, Italy), S. Bernardi (Cuneo, Italy), E. Bernardi (Cuneo, Italy), F. Tosello (Cuneo, Italy), F. Corsini (Cuneo, Italy), B. Lorenzati (Cuneo, Italy), G. Martini (Cuneo, Italy), A. Sciolla (Cuneo, Italy), G. Lauria (Cuneo, Italy)
| |
Risk factors for respiratory failure in patients with COVID-19 pneumonitis: A retrospective study
A. Mobeireek (Riyadh, Saudi Arabia), M. Alhajji (Riyadh, Saudi Arabia), S. Al Saleh (Riyadh, Saudi Arabia), E. Loui (Riyadh, Saudi Arabia), S. Al Amro (Riyadh, Saudi Arabia), A. Al Jebreen (Madinah, Saudi Arabia), A. Torchyan (Riyadh, Saudi Arabia), L. Ahmed (Madinah, Saudi Arabia), L. Ezzat (Riyadh, Saudi Arabia)
| |
COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position
R. Vollenberg (Münster, Germany), M. Strauss (Muenster, Germany), K. Schuette-Nuetgen (Muenster, Germany), H. Schmidt (Muenster, Germany), A. Schulze (Muenster, Germany), P. Tepasse (Muenster, Germany)
| |
Awake Prone Positioning in COVID-19 pneumonia: A useful strategy in resource limited setting
R. Dhar (Kolkata (West Bengal), India), S. Krishnan (Kolkata (West Bengal), India), S. Sharma (Kolkata (West Bengal), India), P. Shahi (Patna, India), M. Sovani (Nottingham, India)
| |
Importance of admission biomarkers in prognostication of patients with SARS-Cov-2
M. Barik (Wakefield, United Kingdom), A. Sawant (Wakefield, United Kingdom)
| |
Challenges in steroids and anicoagulants in severe COVID-19 pneumonia
A. Eldien Thabet Hassan (Assiut, Egypt), A. Abdelmoniem (Assiut, Egypt), M. Mohamed (Assiut, Egypt), A. Elsherif (Al azhar, Egypt), S. Kasim (Assiut, Egypt)
| |
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
E. Barbeta Viñas (Barcelona, Spain), M. Benegas (Barcelona, Spain), M. Sánchez (Barcelona, Spain), A. Motos (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. Lopez (Barcelona, Spain), L. Leticia Bueno (Barcelona, Spain), R. Mellado-Artigas (Barcelona, Spain), C. Ferrando (Barcelona, Spain), L. Ferández-Barat (Barcelona, Spain), N. Albacar (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
The use of High Flow Nasal Oxigen (HFNO) and Non-invasive Ventilation (NIV) in COVID-19
M. Cardone (Naples, Italy), l. capitelli (Naples, Italy), F. Squillante (Naples, Italy)
| |